Paper Details

Paper Title

CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy.

Paper Journal Title

Proc Natl Acad Sci U S A

Paper Citation Count

Paper Publication Year

2017

Bio Mention

-ABL1, ABL1, BCR, CRISPR, Cas9, genomic location, leukemic oncogene BCR, oncogenes, patient

Mesh Descriptor

Author Name	Affiliation
Christopher A Eide	Knight Cancer Institute, Oregon Health & Science University
Christopher A Eide	Howard Hughes Medical Institute, Oregon Health & Science University
Garrett Eickelberg	Knight Cancer Institute, Oregon Health & Science University
Richard D Press	Knight Cancer Institute, Oregon Health & Science University
Lihua Julie Zhu	University of Massachusetts Medical School
Lihua Julie Zhu	University of Massachusetts Medical School
Brian J Druker	Knight Cancer Institute, Oregon Health & Science University
Brian J Druker	Howard Hughes Medical Institute, Oregon Health & Science University
Scot A Wolfe	University of Massachusetts Medical School
Scot A Wolfe	University of Massachusetts Medical School
Jeffrey D Jensen	Ecole Polytechnique Federale de Lausanne
Jeffrey D Jensen
Celia A Schiffer	University of Massachusetts Medical School
Michael R Green	University of Massachusetts Medical School
Michael R Green	Howard Hughes Medical Institute, University of Massachusetts Medical School

Column Actions